• Publications
  • Influence
Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.
OBJECTIVES Because the term "interstitial cystitis" (IC) has different meanings in different centers and different parts of the world, the European Society for the Study of Interstitial CystitisExpand
  • 649
  • 51
  • PDF
Cerebral Blood Flow in Patients With Chronic Heart Failure Before and After Heart Transplantation
Background and Purpose— Arterial blood pressure and cardiac output are often reduced in patients with chronic heart failure (CHF). Counterregulatory mechanisms with increased neurohormonal activationExpand
  • 237
  • 10
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
OBJECTIVES This randomized controlled multicenter trial evaluated coenzyme Q10 (CoQ10) as adjunctive treatment in chronic heart failure (HF). BACKGROUND CoQ10 is an essential cofactor for energyExpand
  • 211
  • 10
Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end‐points of “Q‐symbio” ‐ A multinational trial
Energy starvation of the myocardium is probably a dominant feature of heart failure and attention has been directed towards agents which may stabilize myocardial metabolism and maintain adequateExpand
  • 120
  • 8
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.
BACKGROUND The NOCTET (NOrdic Certican Trial in HEart and lung Transplantation) trial demonstrated that everolimus improves renal function in maintenance thoracic transplant (TTx) recipients.Expand
  • 45
  • 7
Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
Coenzyme Q10 (ubiquinone) the essential mitochondrial redox-component and endogenous antioxidant, packaged into the LDL + VLDL fractions of cholesterol, has been suggested as an important anti-riskExpand
  • 213
  • 5
Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials.
The purpose of this was to investigate the effect of coenzyme Q10 (CoQ10) in patients with congestive heart failure (CHF) by measuring the possible improvement of certain relevant hemodynamic heartExpand
  • 158
  • 5
Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers.
The bioavailability of four different Coenzyme Q10 (CoQ) formulations was compared in ten healthy volunteers in a four-way randomised cross-over trial. The included formulations were: A hard gelatinExpand
  • 92
  • 4
The Effect of Coenzyme Q 10 on Morbidity and Mortality in Chronic Heart Failure Results From Q-SYMBIO : A Randomized Double-Blind Trial
Fro Re leg kF Ko Po Co rel Ma OBJECTIVES This randomized controlled multicenter trial evaluated coenzyme Q10 (CoQ10) as adjunctive treatment in chronic heart failure (HF). BACKGROUND CoQ10 is anExpand
  • 41
  • 4
  • PDF
...
1
2
3
4
5
...